Yong Huo

Yong Huo

Auto-generated profile, based on publicly available information

Yong Huo

Department of Cardiology, Peking University First Hospital, Beijing, China

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2019 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
QZQiwen Zheng
Qiwen Zheng
JJJie Jiang
Jie Jiang
YHYong Huo
Yong Huo
DCDafang Chen
Dafang Chen
Background: Accumulating evidence has shown that type 2 diabetes (T2D) and coronary artery disease (CAD) may stem from a ‘common soil’. The aim of our study was to examine the association between genetic predisposition to T2D and the risk of severe CAD among patients with acute coronary syndromes (ACS) undergoing angiography. Methods: The current case–control study included 1414 ACS patients with at least one major epicardial vessel stenosis > 50% enrolled in the ACS Genetic Study. The severity of CAD was quantified by the number of coronary arteries involved. Genetic risk score (GRS) was calculated using 41 common variants that robustly associated with increased risk of T2D in East Asians. Logistic regression models were used to estimate the association between GRS and the severity of CAD. Results: In the age-, sex- and BMI-adjusted model, each additional risk allele was associated with a 6% increased risk of multi-vessel disease (OR = 1.06, 95% CI 1.02–1.09). The OR was 1.43 (95% CI 1.08–1.89) for the risk of severe CAD when comparing the extreme tertiles of T2D-GRS. The association was not reduced after further adjustment for conventional cardiovascular risk factors. Additional adjustment for T2D status in our regression model attenuated the association by approximately one quarter. In subgroup analysis, the strengths of the associations between GRS and the severity of CAD were broadly similar in terms of baseline demographic information and disease characteristics. Conclusions: Our data indicated that genetic predisposition to T2D is associated with elevated risk of severe CAD. This association revealed a possible causal relationship and is partially mediated through diabetic status.

1 June 2010
Verified
Journal Article
Closed access
WWWei Wang
Wei Wang
YWYang-Feng Wu
Yang-Feng Wu
NZNg Zhao
Ng Zhao
YYYing Yang
Ying Yang
LLLi-Rong Lang
Li-Rong Lang
YHYong Huo
Yong Huo

1 March 2004
Verified
Journal Article
Closed access
JLJian-Ping Li
Jian-Ping Li
XWXiao-Bin Wang
Xiao-Bin Wang
CCChang-Zhong Chen
Chang-Zhong Chen
XXXin Xu
Xin Xu
XHXue-Mei Hong
Xue-Mei Hong
YHYong Huo
Yong Huo

1 January 2007 in Blood Pressure
Verified
Journal Article
Closed access
YHYong Huo
Yong Huo
JZJian Zhang
Jian Zhang
QHQing He
Qing He
HCHong Chen
Hong Chen
JMJishun Ma
Jishun Ma
HLHarald Landen
Harald Landen
This post-marketing surveillance study assessed the efficacy, safety and tolerability of the treatment with nifedipine GITS (gastro-intestinal therapeutic system) in hypertensive patients under normal daily practice conditions in China. A total of 3003 patients were included in 174 outpatient clinics. Patients received 30 mg or 60 mg of nifedipine GITS. Data were collected at up to three follow-up visits. At the end of the observation period, mean treatment duration was 13.3 weeks. Mean blood pressure reduction was 27.6/13.6 mmHg, 62.1% of patients had a systolic blood pressure <140 mmHg, and 82.2% had a diastolic blood pressure <90 mmHg. Blood pressure control according to international guidelines was achieved in 45.0% of all patients. A total of 1515 patients received additional antihypertensive medications, of which angiotensin-converting enzyme (ACE) inhibitors were mostly used (42.2%) followed by beta-blockers (33.7%). Twenty-two patients (0.7%) experienced 27 adverse events. Physicians' assessments of efficacy, tolerability and patient acceptance had ratings of "very good" and "good" in 88.7% (efficacy), 92.8% (tolerability) and 89.1% (patient acceptance) of patients. Nifedipine GITS proved to be effective and well tolerated for the treatment of hypertension in 3003 Chinese patients. The results confirm the findings of previously performed clinical studies.

1 February 2004
Verified
Journal Article
Closed access
ZLZhao-Ping Liu
Zhao-Ping Liu
YHYong Huo
Yong Huo
JLJian-Ping Li
Jian-Ping Li
YZYan Zhang
Yan Zhang
LXLin Xue
Lin Xue
WGWei Gao
Wei Gao

1 December 2010
Verified
Journal Article
Closed access
WWWei Wang
Wei Wang
YHYong Huo
Yong Huo
NZNg Zhao
Ng Zhao
JLJing Liu
Jing Liu
LLLi-Rong Liang
Li-Rong Liang
YWYang-Feng Wu
Yang-Feng Wu